SABRINA CASSELBERRY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHANDLER, AZ NPI 1346902202

General Payments — all program years on this page

$734.61

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $250.70 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $250.7021

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $142.2414
Novo Nordisk AS $32.032
Currax Pharmaceuticals LLC $28.752
Astellas Pharma US Inc $16.681
PFIZER INC. $15.651
Lilly USA, LLC $15.351

By program year

Program yearAmountRecords
2022 $198.9911
2023 $284.9217
2024 $250.7021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089524879 Currax Pharmaceuticals LLC $15.26 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089524881 Currax Pharmaceuticals LLC $13.49 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100577448 Novo Nordisk Inc $17.57 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100606530 Novo Nordisk Inc $14.46 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891027 ABBVIE INC. $15.41 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891029 ABBVIE INC. $17.94 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891031 ABBVIE INC. $8.43 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891033 ABBVIE INC. $23.59 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891035 ABBVIE INC. $8.46 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891037 ABBVIE INC. $12.22 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891039 ABBVIE INC. $5.86 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891041 ABBVIE INC. $8.94 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891043 ABBVIE INC. $8.36 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891045 ABBVIE INC. $8.40 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891047 ABBVIE INC. $6.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891049 ABBVIE INC. $5.16 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891051 ABBVIE INC. $5.96 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106891053 ABBVIE INC. $6.52 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131935272 PFIZER INC. $15.65 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135935298 Lilly USA, LLC $15.35 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139481562 Astellas Pharma US Inc $16.68 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.